3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Breast
3
Conditions
Neoplasms
7
Motor Activity
5
Breast Neoplasms
3
Sedentary Behavior
2
Pancreatic Neoplasms
2
Smoking Cessation
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Neoplasm Metastasis
1
Mobility Limitation
1
Leukemia
1
Fatigue
1
Cigarette Smoking
1
Chronic Disease
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
361
Trastuzumab
352
Paclitaxel
304
Docetaxel
272
Letrozole
221
Capecitabine
221
Carboplatin
185
Doxorubicin
181
Tamoxifen
157
Radiotherapy
154
Epirubicin
145
Fulvestrant
143
Anastrozole
139
Surveys and Questionnaires
132
Exercise
128
pertuzumab
113
Vinorelbine
110
Blood Specimen Collection
109
exemestane
106
palbociclib
104
Bevacizumab
104
pembrolizumab
98
Magnetic Resonance Spectroscopy
97
Albumin-Bound Paclitaxel
87
Gemcitabine
84
Drug Therapy
83
Lapatinib
78
130-nm albumin-bound paclitaxel
72
Neoadjuvant Therapy
71
Cisplatin
69
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Breast Neoplasms
×
Fitness Trackers
×
Clear all
NCT05634395
2025-08-27
GrannyFit
Institut Curie
Phase NA
Active not recruiting
200 enrolled
NCT05011721
2025-03-13
NeoFit
Institut Curie
Phase NA
Completed
300 enrolled
NCT03635723
2024-04-11
BRACELET
Imperial College London
Unknown
75 enrolled